| Age at surgery (years) |
69 (32, 93) |
67 (26, 88) |
0.76 |
| Sex (Male) |
37 (52.9%) |
30 (42.9%) |
0.31 |
| Race (Caucasian) |
67 (95.7%) |
58 (82.9%) |
0.026 |
| BMI |
31.0 (15.9, 59.8) |
31.2 (19.2, 48.6) |
0.83 |
| End stage organ disease |
9 (12.9%) |
2 (2.9%) |
0.055 |
| Transplant |
1 (1.4%) |
1 (1.4%) |
1.00 |
| Inflammatory arthritis on immunomodulators |
4 (5.7%) |
1 (1.4%) |
0.37 |
| Cancer patient on chemotherapy |
2 (2.9%) |
1 (1.4%) |
1.00 |
| Poorly controlled DM (HbA1c > 8) |
3 (4.3%) |
3 (4.3%) |
1.00 |
| ASA classification |
|
|
0.26 |
|
1
|
0 (0.0%) |
1 (1.4%) |
|
|
2
|
24 (34.3%) |
29 (41.4%) |
|
|
3
|
43 (61.4%) |
38 (54.3%) |
|
|
4
|
3 (4.3%) |
2 (2.9%) |
|
| Previous surgery |
36 (51.4%) |
36 (51.4%) |
1.00 |
| Previous open or traumatic wound at site of surgery |
0 (0.0%) |
0 (0.0%) |
1.00 |
| Type of surgery |
|
|
1.00 |
|
TKA
|
35 (50.0%) |
35 (50.0%) |
|
|
THA
|
35 (50.0%) |
35 (50.0%) |
|
| Primary or revision |
|
|
1.00 |
|
Primary
|
34 (48.6%) |
34 (48.6%) |
|
|
Revision
|
36 (51.4%) |
36 (51.4%) |
|